Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 822 of 1,261

  1. US 8697130

    Non-irritating benzoyl peroxide

    Essential Ingredients, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  2. US 8697081

    Method of modulating neovascularization

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  3. US 8697082

    Prevention and treatment of synucleinopathic and amyloidogenic disease

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  4. US 8697125

    Tablet preparation without causing a tableting trouble

    Takeda Pharmaceutical Company Limited · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  5. US 8697048

    Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells

    Northwestern University · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  6. US 8697079

    IgE antibodies for the treatment of cancer

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  7. US 8697076

    Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies

    Northwestern University · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  8. US 8691868

    Neprilysin inhibitors

    Theravance, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  9. US 8691852

    Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

    Amirall, S.A. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  10. US 8692051

    Methods for testing for caloric restriction (CR) mimetics

    BioMarker Pharmaceuticals, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  11. US 8691831

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  12. US 8691849

    3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  13. US 8692052

    Genetically modified mice and engraftment

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  14. US 8691967

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

    Benitec, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  15. US 8691872

    Dispersions of rasagiline citrate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  16. US 8691828

    Thienopyrimidine as CDC7 kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  17. US 8691943

    Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  18. US 8691963

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  19. US 8691184

    Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  20. US 8691859

    Broad spectrum antibacterial compounds

    The United States of America as represented by the Secretary of the Army · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  21. US 8691783

    MicroRNA-24

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  22. US 8691758

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  23. US 8691241

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  24. US 8691813

    Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.